Pfizer Inc. Company Information

Pfizer Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Pfizer Inc.
  • Ticker: PFECL
  • Exchange: SNSE
  • Founded: 1849
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$149.382b
  • Listing Market Cap: US$147.761t
  • Shares Outstanding: 5.67b
  • Website: https://www.pfizer.com

Number of Employees


Location

  • Pfizer Inc.
  • 66 Hudson Boulevard East
  • New York
  • New York
  • 10001-2192
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PFENYSE (New York Stock Exchange)YesCommon StockUSUSDJan 1968
PFE *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNJan 1968
0Q1NLSE (London Stock Exchange)YesCommon StockGBUSDJan 1968
PFEDB (Deutsche Boerse AG)YesCommon StockDEEURJan 1968
PFEXTRA (XETRA Trading Platform)YesCommon StockDEEURJan 1968
PFEBVC (Bolsa de Valores de Colombia)YesCommon StockCOCOPJan 1968
PFESNSE (Santiago Stock Exchange)YesCommon StockCLUSDJan 1968
4PFEETLX (Eurotlx)YesCommon StockITEURJan 1968
PFEWBAG (Wiener Boerse AG)YesCommon StockATEURJan 1968
PFEBVL (Bolsa de Valores de Lima)YesCommon StockPEUSDJan 1968
PFE_KZKAS (Kazakhstan Stock Exchange)YesCommon StockKZUSDJan 1968
PFEBUL (Bulgaria Stock Exchange)YesCommon StockBGEURJan 1968
PFECLSNSE (Santiago Stock Exchange)YesCommon StockCLCLPJan 1968
PFEDBATS-CHIXE (BATS 'Chi-X Europe')YesCommon StockGBEURJan 1968
PFEBASE (Buenos Aires Stock Exchange)CEDEAR EACH 4 REP 1 ORD USD0.05ARARSSep 2000
PFEDBASE (Buenos Aires Stock Exchange)CEDEAR EACH 4 REP 1 ORD USD0.05ARUSDSep 2000
PFIZ34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 4 REP 1 COMBRBRLMay 2011
PFEBDB (Deutsche Boerse AG)CDR CAD HEDGEDDEEURDec 2021
PFENEOE (Aequitas Neo Exchange)CDR CAD HEDGEDCACADDec 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/12/22 18:32
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/29
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 18:32
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/29
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pfizer Inc. is covered by 55 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Ishan MajumdarBaptista Research
Alistair CampbellBerenberg